Literature DB >> 31602871

[Advances on network pharmacology in ethnomedicine research].

Mei-Wen Huang1, Hua-Jie Yang2, Xiao-Chun Zhou1, Fu-Xing Ge1, Shun-Gang Jiao1, Peng-Fei Tu1, Yuan-Yuan Xie3, Xing-Yun Chai1.   

Abstract

Ethnomedicine is the precious wealth left by ethnic minorities in their struggle against diseases. It is similar to traditional Chinese medicine in a narrow sense and has the characteristics of multi-component,multi-target and multi-channel synergy. Under the guidance of the theory of ethnomedicine,the combination of ethnomedicine and network pharmacology will help to understand the essence of the prevention and treatment of ethnomedicines in a dynamic and holistic manner. This paper reviews the research progress of network pharmacology applied in ethnomedicine,analyses the problems and challenges existing in the application of network pharmacology in ethnomedicine research at present,such as inaccurate data and information,lack of network analysis platform for effective analysis of dose-effect relationship of chemical constituents and weak basic research of ethnomedicine,and puts forward corresponding prospects.

Keywords:  effective material basis; ethnomedicine; mechanism of action; network pharmacology; systems biology

Mesh:

Year:  2019        PMID: 31602871     DOI: 10.19540/j.cnki.cjcmm.20190711.201

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?

Authors:  Zhenjie Zhuang; Junmao Wen; Lu Zhang; Mingjia Zhang; Xiaoying Zhong; Huiqi Chen; Chuanjin Luo
Journal:  Eur J Integr Med       Date:  2020-05-26       Impact factor: 1.314

2.  Network Pharmacology Analysis of Huangqi Jianzhong Tang Targets in Gastric Cancer.

Authors:  Long Li; Yizhuo Lu; Yanling Liu; Dan Wang; Linshan Duan; Shuyu Cheng; Guoyan Liu
Journal:  Front Pharmacol       Date:  2022-04-08       Impact factor: 5.988

3.  Network Pharmacology-Based Approach to Investigate the Molecular Targets of Rhubarb for Treating Cancer.

Authors:  Lan Jiang; Zhongquan Shi; Yi Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-08       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.